{"id":{"repo_id":"cornell","oai_identifier":"oai:ecommons.cornell.edu:1813/43597"},"canonical_url":"https://search.ndltd.org/etd/cornell/oai:ecommons.cornell.edu:1813/43597","repository":{"repo_id":"cornell","name":"Cornell University","base_url":"https://ecommons.cornell.edu/server/oai/request"},"display":{"title":"Investigation Of The Innate Immune Response To Circulating Tumor Cells In Preclinical Animal Models Of Cancer Metastasis","abstract":"Metastasis is the leading cause of death in cancer patients because of the difficulty to treat the secondary tumors and the latency period between dissemination of metastatic cells from the primary tumor to other sites and clinical detection. As such, metastasis accounts for a considerable bulk of the $100 billion yearly cost of cancer medical treatment. Understanding the mechanisms underlying metastasis events could have an enormous impact on patient survival rates and how clinicians and scientists target drugs to reduce metastasis. Targeting CTCs has garnered much attention as a therapeutic target in recent years. They are a bottleneck in the progressive stages of metastasis. My thesis explores how circulating tumor cells interact with the host environment and the host innate immune response that ensues. There are two host environments that I investigate 1) blood circulation where circulating tumor cells come in contact with white blood cells and 2) the inflammatory cells in a secondary organ, in this case the brain. My methods include extensive use of transgenic animal models, two-photon microscopy, bioluminescence imaging and imaging analysis. The work presented in this dissertation contributes information about how the innate immune system can be used as a therapeutic drug carrier to target CTCs.","abstract_html":"Metastasis is the leading cause of death in cancer patients because of the difficulty to treat the secondary tumors and the latency period between dissemination of metastatic cells from the primary tumor to other sites and clinical detection. As such, metastasis accounts for a considerable bulk of the $100 billion yearly cost of cancer medical treatment. Understanding the mechanisms underlying metastasis events could have an enormous impact on patient survival rates and how clinicians and scientists target drugs to reduce metastasis. Targeting CTCs has garnered much attention as a therapeutic target in recent years. They are a bottleneck in the progressive stages of metastasis. My thesis explores how circulating tumor cells interact with the host environment and the host innate immune response that ensues. There are two host environments that I investigate 1) blood circulation where circulating tumor cells come in contact with white blood cells and 2) the inflammatory cells in a secondary organ, in this case the brain. My methods include extensive use of transgenic animal models, two-photon microscopy, bioluminescence imaging and imaging analysis. The work presented in this dissertation contributes information about how the innate immune system can be used as a therapeutic drug carrier to target CTCs.","abstract_has_math":false,"creators":["Wayne, Elizabeth"],"institution":"Cornell University","degree_name":"Ph. D., Biomedical Engineering","degree_level":"Doctor of Philosophy","degree_discipline":"Biomedical Engineering","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":["Schaffer,Chris"],"committee_members":["Schimenti,John C.","Wise,Frank William","King,Michael R."],"year":2016,"date_issued":"2016-02-01","date_published":"2016-02-01","updated_at":"2026-11-19T03:19:03Z","subjects":["circulating tumor cells","metastasis","optical imaging"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["9597013"],"render_values":[{"text":"9597013","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1813/43597","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/1813/43597","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://ecommons.cornell.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aecommons.cornell.edu%3A1813%2F43597","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.chair","label":"Chair","values":["Schaffer,Chris"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Schimenti,John C.","Wise,Frank William","King,Michael R."]},{"key":"dc:creator","label":"Author","values":["Wayne, Elizabeth"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2016-04-04T18:05:13Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2016-04-04T18:05:13Z"]},{"key":"dc:date.issued","label":"Date","values":["2016-02-01"]},{"key":"dc:type","label":"Dc Type","values":["dissertation or thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctor of Philosophy"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph. D., Biomedical Engineering"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Cornell University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["circulating tumor cells","metastasis","optical imaging"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["9597013"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1813/43597"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"cerif:openaire","label":"Cerif Openaire","values":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"e926e420-9f0a-4d01-a9b1-62e902115f6a\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en_US</Language> <Title>Investigation Of The Innate Immune Response To Circulating Tumor Cells In Preclinical Animal Models Of Cancer Metastasis</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2016-02-01</PublicationDate> <Authors> <Author> <DisplayName>Wayne, Elizabeth</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <Keyword>circulating tumor cells</Keyword> <Keyword>metastasis</Keyword> <Keyword>optical imaging</Keyword> <Abstract>Metastasis is the leading cause of death in cancer patients because of the difficulty to treat the secondary tumors and the latency period between dissemination of metastatic cells from the primary tumor to other sites and clinical detection. As such, metastasis accounts for a considerable bulk of the $100 billion yearly cost of cancer medical treatment. Understanding the mechanisms underlying metastasis events could have an enormous impact on patient survival rates and how clinicians and scientists target drugs to reduce metastasis. Targeting CTCs has garnered much attention as a therapeutic target in recent years. They are a bottleneck in the progressive stages of metastasis. My thesis explores how circulating tumor cells interact with the host environment and the host innate immune response that ensues. There are two host environments that I investigate 1) blood circulation where circulating tumor cells come in contact with white blood cells and 2) the inflammatory cells in a secondary organ, in this case the brain. My methods include extensive use of transgenic animal models, two-photon microscopy, bioluminescence imaging and imaging analysis. The work presented in this dissertation contributes information about how the innate immune system can be used as a therapeutic drug carrier to target CTCs.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"]},{"key":"cris:virtual.author","label":"Cris Virtual Author","values":["Wayne, Elizabeth"]},{"key":"cris:virtualsource.collection","label":"Cris Virtualsource Collection","values":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"]},{"key":"dc:description.abstract","label":"Abstract","values":["Metastasis is the leading cause of death in cancer patients because of the difficulty to treat the secondary tumors and the latency period between dissemination of metastatic cells from the primary tumor to other sites and clinical detection. As such, metastasis accounts for a considerable bulk of the $100 billion yearly cost of cancer medical treatment. Understanding the mechanisms underlying metastasis events could have an enormous impact on patient survival rates and how clinicians and scientists target drugs to reduce metastasis. Targeting CTCs has garnered much attention as a therapeutic target in recent years. They are a bottleneck in the progressive stages of metastasis. My thesis explores how circulating tumor cells interact with the host environment and the host innate immune response that ensues. There are two host environments that I investigate 1) blood circulation where circulating tumor cells come in contact with white blood cells and 2) the inflammatory cells in a secondary organ, in this case the brain. My methods include extensive use of transgenic animal models, two-photon microscopy, bioluminescence imaging and imaging analysis. The work presented in this dissertation contributes information about how the innate immune system can be used as a therapeutic drug carrier to target CTCs."]},{"key":"dc:description.collection","label":"Dc Description Collection","values":["Cornell Theses and Dissertations"]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Investigation Of The Innate Immune Response To Circulating Tumor Cells In Preclinical Animal Models Of Cancer Metastasis"]},{"key":"dspace:entity.type","label":"Dspace Entity Type","values":["Publication"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"cerif:openaire":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"e926e420-9f0a-4d01-a9b1-62e902115f6a\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en_US</Language> <Title>Investigation Of The Innate Immune Response To Circulating Tumor Cells In Preclinical Animal Models Of Cancer Metastasis</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2016-02-01</PublicationDate> <Authors> <Author> <DisplayName>Wayne, Elizabeth</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <Keyword>circulating tumor cells</Keyword> <Keyword>metastasis</Keyword> <Keyword>optical imaging</Keyword> <Abstract>Metastasis is the leading cause of death in cancer patients because of the difficulty to treat the secondary tumors and the latency period between dissemination of metastatic cells from the primary tumor to other sites and clinical detection. As such, metastasis accounts for a considerable bulk of the $100 billion yearly cost of cancer medical treatment. Understanding the mechanisms underlying metastasis events could have an enormous impact on patient survival rates and how clinicians and scientists target drugs to reduce metastasis. Targeting CTCs has garnered much attention as a therapeutic target in recent years. They are a bottleneck in the progressive stages of metastasis. My thesis explores how circulating tumor cells interact with the host environment and the host innate immune response that ensues. There are two host environments that I investigate 1) blood circulation where circulating tumor cells come in contact with white blood cells and 2) the inflammatory cells in a secondary organ, in this case the brain. My methods include extensive use of transgenic animal models, two-photon microscopy, bioluminescence imaging and imaging analysis. The work presented in this dissertation contributes information about how the innate immune system can be used as a therapeutic drug carrier to target CTCs.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"],"cris:virtual.author":["Wayne, Elizabeth"],"cris:virtualsource.collection":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"],"dc:contributor.chair":["Schaffer,Chris"],"dc:contributor.committeemember":["Schimenti,John C.","Wise,Frank William","King,Michael R."],"dc:creator":["Wayne, Elizabeth"],"dc:date.accessioned":["2016-04-04T18:05:13Z"],"dc:date.available":["2016-04-04T18:05:13Z"],"dc:date.issued":["2016-02-01"],"dc:description.abstract":["Metastasis is the leading cause of death in cancer patients because of the difficulty to treat the secondary tumors and the latency period between dissemination of metastatic cells from the primary tumor to other sites and clinical detection. As such, metastasis accounts for a considerable bulk of the $100 billion yearly cost of cancer medical treatment. Understanding the mechanisms underlying metastasis events could have an enormous impact on patient survival rates and how clinicians and scientists target drugs to reduce metastasis. Targeting CTCs has garnered much attention as a therapeutic target in recent years. They are a bottleneck in the progressive stages of metastasis. My thesis explores how circulating tumor cells interact with the host environment and the host innate immune response that ensues. There are two host environments that I investigate 1) blood circulation where circulating tumor cells come in contact with white blood cells and 2) the inflammatory cells in a secondary organ, in this case the brain. My methods include extensive use of transgenic animal models, two-photon microscopy, bioluminescence imaging and imaging analysis. The work presented in this dissertation contributes information about how the innate immune system can be used as a therapeutic drug carrier to target CTCs."],"dc:description.collection":["Cornell Theses and Dissertations"],"dc:format.mimetype":["application/pdf"],"dc:identifier.bibid":["9597013"],"dc:identifier.uri":["https://hdl.handle.net/1813/43597"],"dc:language.iso":["en_US"],"dc:subject":["circulating tumor cells","metastasis","optical imaging"],"dc:title":["Investigation Of The Innate Immune Response To Circulating Tumor Cells In Preclinical Animal Models Of Cancer Metastasis"],"dc:type":["dissertation or thesis"],"dspace:entity.type":["Publication"],"others:access_status":["open.access"],"thesis:degree_discipline":["Biomedical Engineering"],"thesis:degree_level":["Doctor of Philosophy"],"thesis:degree_name":["Ph. D., Biomedical Engineering"],"thesis:institution_name":["Cornell University"]},"updated_at":"2026-11-19T03:19:03Z"}